CIK 0001581178 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in A1 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-15 | 6-K | FORM 6-K | 2026-10-15 |
| 2026-10-09 | 6-K | FORM 6-K | 2026-10-09 |
| 2026-09-30 | 6-K | FORM 6-K | 2026-09-30 |
| 2026-09-08 | 6-K | FORM 6-K | 2026-09-08 |
| 2026-09-02 | SUPPL | SUPPL | |
| 2026-08-24 | EFFECT | EFFECT items ,, | |
| 2026-08-19 | F-10/A | F-10/A | |
| 2026-08-13 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-13 | 6-K | FORM 6-K | 2026-08-13 |
| 2026-08-11 | 6-K | 6-K | 2026-08-11 |
| 2026-08-06 | F-X | F-X | |
| 2026-08-06 | F-10 | F-10 | |
| 2026-07-15 | 6-K | FORM 6-K | 2026-07-15 |
| 2026-07-13 | 6-K | FORM 6-K | 2026-07-13 |
| 2026-07-07 | 6-K | FORM 6-K | 2026-07-07 |
| 2026-06-22 | 6-K | FORM 6-K | 2026-06-19 |
| 2026-05-29 | 6-K | FORM 6-K | 2026-06-18 |
| 2026-05-29 | 6-K | FORM 6-K | 2026-05-28 |
| 2026-05-28 | 6-K | FORM 6-K | 2026-05-28 |
| 2026-05-12 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-12 | 6-K | 6-K | 2026-05-12 |
| 2026-05-06 | 6-K | FORM 6-K | 2026-05-06 |
| 2026-05-05 | 6-K | FORM 6-K | 2026-05-05 |
| 2026-05-01 | 6-K | FORM 6-K | 2026-05-01 |
| 2026-04-22 | 6-K | FORM 6-K | 2026-04-22 |
Forms on file (last 1,000): 6-K 87, D 8, SUPPL 5, SCHEDULE 13G/A 4, 40-F 3, EFFECT 2, F-10/A 2, F-X 2. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=EPRX (0.002 USD), /gw/filings/filings?ticker=EPRX&form=8-K, /gw/filings/facts?ticker=EPRX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange